Speaker
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Mike Jones, Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development at Takeda Pharmaceutical, appears in the programmes of 2 conferences on kongre.net. Most recently: 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026).
27–29 Oct 2026Boston, United States of America
9–10 Sept 2026Boston, United States of America
Chief Medical Officer, ModeX Therapeutics
Senior Vice President & Head of Research, GV20 Therapeutics LLC
Chief Business Officer, NovalGen
Senior Scientist, Translational Biology, Rondo Therapeutics
Co-Founder, CEO & President, Reverb Therapeutics Inc.
Program Director, Hanson Wade
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Science Partner, Flagship Pioneering
Chief Business Officer, Nurix Therapeutics, Inc.
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Chief Executive Officer, Synthis Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mike Jones, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].